Two Sigma Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-581,600
| Closed | -$10.5M | – | 2742 |
|
|
2020
Q2 | $10.5M | Sell |
581,600
-174,200
| -23% | -$2.42M | 0.03% | 533 |
|
|
2020
Q1 | $5.39M | Buy |
755,800
+396,100
| +110% | +$4.94M | 0.02% | 686 |
|
|
2019
Q4 | $8.59M | Buy |
359,700
+11,900
| +3% | +$328K | 0.02% | 640 |
|
|
2019
Q3 | $9.33M | Buy |
347,800
+111,700
| +47% | +$3.14M | 0.02% | 563 |
|
|
2019
Q2 | $6.41M | Buy |
+236,100
| New | +$7.4M | 0.02% | 734 |
|
|
2018
Q2 | – | Sell |
-23,800
| Closed | -$777K | – | 2558 |
|
|
2018
Q1 | $777K | Sell |
23,800
-331,900
| -93% | -$14.6M | ﹤0.01% | 1650 |
|
|
2017
Q4 | $17.3M | Buy |
355,700
+162,800
| +84% | +$8.23M | 0.05% | 441 |
|
|
2017
Q3 | $10.4M | Buy |
192,900
+39,509
| +26% | +$2.32M | 0.03% | 550 |
|
|
2017
Q2 | $8.62M | Buy |
153,391
+139,655
| +1,017% | +$5.59M | 0.03% | 554 |
|
|
2017
Q1 | $538K | Buy |
+13,736
| New | +$437K | ﹤0.01% | 1860 |
|
|
2016
Q3 | – | Sell |
-58,500
| Closed | -$1.38M | – | 2359 |
|
|
2016
Q2 | $1.38M | Buy |
58,500
+5,500
| +10% | +$136K | 0.01% | 1016 |
|
|
2016
Q1 | $1.08M | Buy |
53,000
+39,900
| +305% | +$1.27M | 0.01% | 1085 |
|
|
2015
Q4 | $674K | Buy |
13,100
+5,400
| +70% | +$262K | ﹤0.01% | 1210 |
|
|
2015
Q3 | $328K | Sell |
7,700
-3,300
| -30% | -$159K | ﹤0.01% | 1458 |
|
|
2015
Q2 | $501K | Sell |
11,000
-35,400
| -76% | -$1.42M | ﹤0.01% | 1420 |
|
|
2015
Q1 | $1.76M | Buy |
46,400
+36,400
| +364% | +$1.25M | 0.01% | 829 |
|
|
2014
Q4 | $283K | Buy |
+10,000
| New | +$278K | ﹤0.01% | 1983 |
|
Two Sigma Advisers's PTLA Position: Q3 2020 in Review
Two Sigma Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 581,600 shares — an estimated $10.5M sold.
Two Sigma Advisers first reported a position in PTLA in Q4 2014 and held it in 17 quarters. The position peaked at $17.3M in Q4 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Two Sigma Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Two Sigma Advisers sold 581,600 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $10.5M.
- Two Sigma Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 17 quarters.
- Two Sigma Advisers's Portola Pharmaceuticals, Inc. position peaked at $17.3M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Two Sigma Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.